tiprankstipranks
Aequus Pharmaceuticals Inc (TSE:AQS)
:AQS
Canadian Market
AQS
Aequus Pharmaceuticals
RESEARCH TOOLSreports
Want to see TSE:AQS full AI Analyst Report?

Aequus Pharmaceuticals (AQS) Financial Statements

14 Followers

Aequus Pharmaceuticals Financial Overview

Aequus Pharmaceuticals's market cap is currently C$663.17K. The company's EPS TTM is C$0; its P/E ratio is -1.01; Aequus Pharmaceuticals is scheduled to report earnings on May 6, 2026, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Dec 21Mar 21
Income Statement
Total RevenueC$ 584.24KC$ 254.90KC$ 1.38MC$ 2.71MC$ 2.59M
Gross ProfitC$ 199.97KC$ 143.66KC$ 1.15MC$ 2.69MC$ 2.59M
Operating IncomeC$ -2.13MC$ -2.82MC$ -2.50MC$ -1.35MC$ -521.57K
EBITDAC$ -1.79MC$ -2.68MC$ -2.87MC$ -1.23MC$ -314.80K
Net IncomeC$ -2.18MC$ -2.96MC$ -3.21MC$ -1.81MC$ -1.05M
Balance Sheet
Cash & Short-Term InvestmentsC$ 50.24KC$ 170.20KC$ 294.67KC$ 2.39MC$ 1.72M
Total AssetsC$ 800.28KC$ 1.09MC$ 1.69MC$ 4.35MC$ 3.13M
Total DebtC$ 6.61MC$ 5.06MC$ 782.92KC$ 2.18MC$ 2.32M
Net DebtC$ 6.56MC$ 4.89MC$ 533.10KC$ -211.31KC$ 604.74K
Total LiabilitiesC$ 7.26MC$ 5.38MC$ 3.07MC$ 2.56MC$ 2.56M
Stockholders' EquityC$ -6.45MC$ -4.29MC$ -1.38MC$ 1.79MC$ 573.95K
Cash Flow
Free Cash FlowC$ -1.66MC$ -2.29MC$ -1.95MC$ -1.18MC$ -817.23K
Operating Cash FlowC$ -1.66MC$ -2.29MC$ -1.95MC$ -1.17MC$ -804.91K
Investing Cash FlowC$ 44.85KC$ 0.00C$ 0.00C$ -507.96KC$ -12.32K
Financing Cash FlowC$ 1.49MC$ 2.21MC$ -189.19KC$ 2.40MC$ 2.05M
Currency in CAD

Aequus Pharmaceuticals Earnings and Revenue History

Income Statement >

Aequus Pharmaceuticals Debt to Assets

Balance Sheet >

Aequus Pharmaceuticals Cash Flow

Cash Flow >

Aequus Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >